The Experts below are selected from a list of 620412 Experts worldwide ranked by ideXlab platform
Linda M Ercoli - One of the best experts on this subject based on the ideXlab platform.
-
cognitive rehabilitation Group Intervention for breast cancer survivors results of a randomized clinical trial
Psycho-oncology, 2015Co-Authors: Linda M Ercoli, Laura Petersen, Aimee M Hunter, Steven A Castellon, Lorna Kwan, B A Kahnmills, L M EmbreeAbstract:Author(s): Ercoli, LM; Petersen, L; Hunter, AM; Castellon, SA; Kwan, L; Kahn-Mills, BA; Embree, LM; Cernin, PA; Leuchter, AF; Ganz, PA | Abstract: We conducted a randomized clinical trial evaluating the efficacy of a cognitive rehabilitation (CR) Intervention compared with a wait list (WL) control condition on cognitive complaints, neuropsychological and brain functioning in breast cancer survivors (BCS).The small Group Intervention of five sessions included psychoeducation and cognitive exercises.Disease-free BCS with cognitive complaints, diagnosed with stage I, II or III breast cancer, completed primary treatment 18 months to 5 years earlier. Neurocognitive test data and cognitive complaints on the Patient's Assessment of Own Functioning Inventory (PAOFI) were assessed at baseline (T1), immediately post-Intervention (T2), and 2 months later (T3). A subGroup of participants underwent resting state quantitative electroencephalography (qEEG) at all three assessment time points.Forty-eight participants [mean age (SD) 53.8 (8.2)] completed T1 assessments, and 29 participants had analyzable qEEG data. The CR Group improved significantly over time compared with the WL Group on PAOFI total and memory scores (both p = .01) and on Rey Auditory Verbal Learning Test (RAVLT) total (trials I-V) (p = .02) and RAVLT delayed recall (p = .007) scores. On qEEG, the CR Group showed a significant decrease in delta 'slow wave' power (p = .02) and an increase in the frontal distribution of alpha power (p = .04) from T1 to T2.BCS in the CR Group showed immediate and sustained improvements in self-reported cognitive complaints and memory functioning on neurocognitive testing. Results of the qEEG substudy provide some support for neurophysiological changes underlying the Intervention. Copyright © 2015 John Wiley a Sons, Ltd.
-
cognitive rehabilitation Group Intervention for breast cancer survivors results of a randomized clinical trial
Psycho-oncology, 2015Co-Authors: Linda M Ercoli, Laura Petersen, Aimee M Hunter, Steven A Castellon, Lorna Kwan, B A Kahnmills, L M EmbreeAbstract:Author(s): Ercoli, LM; Petersen, L; Hunter, AM; Castellon, SA; Kwan, L; Kahn-Mills, BA; Embree, LM; Cernin, PA; Leuchter, AF; Ganz, PA | Abstract: PurposeWe conducted a randomized clinical trial evaluating the efficacy of a cognitive rehabilitation (CR) Intervention compared with a wait list (WL) control condition on cognitive complaints, neuropsychological and brain functioning in breast cancer survivors (BCS).MethodsThe small Group Intervention of five sessions included psychoeducation and cognitive exercises.EligibilityDisease-free BCS with cognitive complaints, diagnosed with stage I, II or III breast cancer, completed primary treatment 18 months to 5 years earlier. Neurocognitive test data and cognitive complaints on the Patient's Assessment of Own Functioning Inventory (PAOFI) were assessed at baseline (T1), immediately post-Intervention (T2), and 2 months later (T3). A subGroup of participants underwent resting state quantitative electroencephalography (qEEG) at all three assessment time points.ResultsForty-eight participants [mean age (SD) 53.8 (8.2)] completed T1 assessments, and 29 participants had analyzable qEEG data. The CR Group improved significantly over time compared with the WL Group on PAOFI total and memory scores (both p = .01) and on Rey Auditory Verbal Learning Test (RAVLT) total (trials I-V) (p = .02) and RAVLT delayed recall (p = .007) scores. On qEEG, the CR Group showed a significant decrease in delta 'slow wave' power (p = .02) and an increase in the frontal distribution of alpha power (p = .04) from T1 to T2.ConclusionsBCS in the CR Group showed immediate and sustained improvements in self-reported cognitive complaints and memory functioning on neurocognitive testing. Results of the qEEG substudy provide some support for neurophysiological changes underlying the Intervention. Copyright © 2015 John Wiley a Sons, Ltd.
L M Embree - One of the best experts on this subject based on the ideXlab platform.
-
cognitive rehabilitation Group Intervention for breast cancer survivors results of a randomized clinical trial
Psycho-oncology, 2015Co-Authors: Linda M Ercoli, Laura Petersen, Aimee M Hunter, Steven A Castellon, Lorna Kwan, B A Kahnmills, L M EmbreeAbstract:Author(s): Ercoli, LM; Petersen, L; Hunter, AM; Castellon, SA; Kwan, L; Kahn-Mills, BA; Embree, LM; Cernin, PA; Leuchter, AF; Ganz, PA | Abstract: We conducted a randomized clinical trial evaluating the efficacy of a cognitive rehabilitation (CR) Intervention compared with a wait list (WL) control condition on cognitive complaints, neuropsychological and brain functioning in breast cancer survivors (BCS).The small Group Intervention of five sessions included psychoeducation and cognitive exercises.Disease-free BCS with cognitive complaints, diagnosed with stage I, II or III breast cancer, completed primary treatment 18 months to 5 years earlier. Neurocognitive test data and cognitive complaints on the Patient's Assessment of Own Functioning Inventory (PAOFI) were assessed at baseline (T1), immediately post-Intervention (T2), and 2 months later (T3). A subGroup of participants underwent resting state quantitative electroencephalography (qEEG) at all three assessment time points.Forty-eight participants [mean age (SD) 53.8 (8.2)] completed T1 assessments, and 29 participants had analyzable qEEG data. The CR Group improved significantly over time compared with the WL Group on PAOFI total and memory scores (both p = .01) and on Rey Auditory Verbal Learning Test (RAVLT) total (trials I-V) (p = .02) and RAVLT delayed recall (p = .007) scores. On qEEG, the CR Group showed a significant decrease in delta 'slow wave' power (p = .02) and an increase in the frontal distribution of alpha power (p = .04) from T1 to T2.BCS in the CR Group showed immediate and sustained improvements in self-reported cognitive complaints and memory functioning on neurocognitive testing. Results of the qEEG substudy provide some support for neurophysiological changes underlying the Intervention. Copyright © 2015 John Wiley a Sons, Ltd.
-
cognitive rehabilitation Group Intervention for breast cancer survivors results of a randomized clinical trial
Psycho-oncology, 2015Co-Authors: Linda M Ercoli, Laura Petersen, Aimee M Hunter, Steven A Castellon, Lorna Kwan, B A Kahnmills, L M EmbreeAbstract:Author(s): Ercoli, LM; Petersen, L; Hunter, AM; Castellon, SA; Kwan, L; Kahn-Mills, BA; Embree, LM; Cernin, PA; Leuchter, AF; Ganz, PA | Abstract: PurposeWe conducted a randomized clinical trial evaluating the efficacy of a cognitive rehabilitation (CR) Intervention compared with a wait list (WL) control condition on cognitive complaints, neuropsychological and brain functioning in breast cancer survivors (BCS).MethodsThe small Group Intervention of five sessions included psychoeducation and cognitive exercises.EligibilityDisease-free BCS with cognitive complaints, diagnosed with stage I, II or III breast cancer, completed primary treatment 18 months to 5 years earlier. Neurocognitive test data and cognitive complaints on the Patient's Assessment of Own Functioning Inventory (PAOFI) were assessed at baseline (T1), immediately post-Intervention (T2), and 2 months later (T3). A subGroup of participants underwent resting state quantitative electroencephalography (qEEG) at all three assessment time points.ResultsForty-eight participants [mean age (SD) 53.8 (8.2)] completed T1 assessments, and 29 participants had analyzable qEEG data. The CR Group improved significantly over time compared with the WL Group on PAOFI total and memory scores (both p = .01) and on Rey Auditory Verbal Learning Test (RAVLT) total (trials I-V) (p = .02) and RAVLT delayed recall (p = .007) scores. On qEEG, the CR Group showed a significant decrease in delta 'slow wave' power (p = .02) and an increase in the frontal distribution of alpha power (p = .04) from T1 to T2.ConclusionsBCS in the CR Group showed immediate and sustained improvements in self-reported cognitive complaints and memory functioning on neurocognitive testing. Results of the qEEG substudy provide some support for neurophysiological changes underlying the Intervention. Copyright © 2015 John Wiley a Sons, Ltd.
Steven A Castellon - One of the best experts on this subject based on the ideXlab platform.
-
cognitive rehabilitation Group Intervention for breast cancer survivors results of a randomized clinical trial
Psycho-oncology, 2015Co-Authors: Linda M Ercoli, Laura Petersen, Aimee M Hunter, Steven A Castellon, Lorna Kwan, B A Kahnmills, L M EmbreeAbstract:Author(s): Ercoli, LM; Petersen, L; Hunter, AM; Castellon, SA; Kwan, L; Kahn-Mills, BA; Embree, LM; Cernin, PA; Leuchter, AF; Ganz, PA | Abstract: We conducted a randomized clinical trial evaluating the efficacy of a cognitive rehabilitation (CR) Intervention compared with a wait list (WL) control condition on cognitive complaints, neuropsychological and brain functioning in breast cancer survivors (BCS).The small Group Intervention of five sessions included psychoeducation and cognitive exercises.Disease-free BCS with cognitive complaints, diagnosed with stage I, II or III breast cancer, completed primary treatment 18 months to 5 years earlier. Neurocognitive test data and cognitive complaints on the Patient's Assessment of Own Functioning Inventory (PAOFI) were assessed at baseline (T1), immediately post-Intervention (T2), and 2 months later (T3). A subGroup of participants underwent resting state quantitative electroencephalography (qEEG) at all three assessment time points.Forty-eight participants [mean age (SD) 53.8 (8.2)] completed T1 assessments, and 29 participants had analyzable qEEG data. The CR Group improved significantly over time compared with the WL Group on PAOFI total and memory scores (both p = .01) and on Rey Auditory Verbal Learning Test (RAVLT) total (trials I-V) (p = .02) and RAVLT delayed recall (p = .007) scores. On qEEG, the CR Group showed a significant decrease in delta 'slow wave' power (p = .02) and an increase in the frontal distribution of alpha power (p = .04) from T1 to T2.BCS in the CR Group showed immediate and sustained improvements in self-reported cognitive complaints and memory functioning on neurocognitive testing. Results of the qEEG substudy provide some support for neurophysiological changes underlying the Intervention. Copyright © 2015 John Wiley a Sons, Ltd.
-
cognitive rehabilitation Group Intervention for breast cancer survivors results of a randomized clinical trial
Psycho-oncology, 2015Co-Authors: Linda M Ercoli, Laura Petersen, Aimee M Hunter, Steven A Castellon, Lorna Kwan, B A Kahnmills, L M EmbreeAbstract:Author(s): Ercoli, LM; Petersen, L; Hunter, AM; Castellon, SA; Kwan, L; Kahn-Mills, BA; Embree, LM; Cernin, PA; Leuchter, AF; Ganz, PA | Abstract: PurposeWe conducted a randomized clinical trial evaluating the efficacy of a cognitive rehabilitation (CR) Intervention compared with a wait list (WL) control condition on cognitive complaints, neuropsychological and brain functioning in breast cancer survivors (BCS).MethodsThe small Group Intervention of five sessions included psychoeducation and cognitive exercises.EligibilityDisease-free BCS with cognitive complaints, diagnosed with stage I, II or III breast cancer, completed primary treatment 18 months to 5 years earlier. Neurocognitive test data and cognitive complaints on the Patient's Assessment of Own Functioning Inventory (PAOFI) were assessed at baseline (T1), immediately post-Intervention (T2), and 2 months later (T3). A subGroup of participants underwent resting state quantitative electroencephalography (qEEG) at all three assessment time points.ResultsForty-eight participants [mean age (SD) 53.8 (8.2)] completed T1 assessments, and 29 participants had analyzable qEEG data. The CR Group improved significantly over time compared with the WL Group on PAOFI total and memory scores (both p = .01) and on Rey Auditory Verbal Learning Test (RAVLT) total (trials I-V) (p = .02) and RAVLT delayed recall (p = .007) scores. On qEEG, the CR Group showed a significant decrease in delta 'slow wave' power (p = .02) and an increase in the frontal distribution of alpha power (p = .04) from T1 to T2.ConclusionsBCS in the CR Group showed immediate and sustained improvements in self-reported cognitive complaints and memory functioning on neurocognitive testing. Results of the qEEG substudy provide some support for neurophysiological changes underlying the Intervention. Copyright © 2015 John Wiley a Sons, Ltd.
Aimee M Hunter - One of the best experts on this subject based on the ideXlab platform.
-
cognitive rehabilitation Group Intervention for breast cancer survivors results of a randomized clinical trial
Psycho-oncology, 2015Co-Authors: Linda M Ercoli, Laura Petersen, Aimee M Hunter, Steven A Castellon, Lorna Kwan, B A Kahnmills, L M EmbreeAbstract:Author(s): Ercoli, LM; Petersen, L; Hunter, AM; Castellon, SA; Kwan, L; Kahn-Mills, BA; Embree, LM; Cernin, PA; Leuchter, AF; Ganz, PA | Abstract: We conducted a randomized clinical trial evaluating the efficacy of a cognitive rehabilitation (CR) Intervention compared with a wait list (WL) control condition on cognitive complaints, neuropsychological and brain functioning in breast cancer survivors (BCS).The small Group Intervention of five sessions included psychoeducation and cognitive exercises.Disease-free BCS with cognitive complaints, diagnosed with stage I, II or III breast cancer, completed primary treatment 18 months to 5 years earlier. Neurocognitive test data and cognitive complaints on the Patient's Assessment of Own Functioning Inventory (PAOFI) were assessed at baseline (T1), immediately post-Intervention (T2), and 2 months later (T3). A subGroup of participants underwent resting state quantitative electroencephalography (qEEG) at all three assessment time points.Forty-eight participants [mean age (SD) 53.8 (8.2)] completed T1 assessments, and 29 participants had analyzable qEEG data. The CR Group improved significantly over time compared with the WL Group on PAOFI total and memory scores (both p = .01) and on Rey Auditory Verbal Learning Test (RAVLT) total (trials I-V) (p = .02) and RAVLT delayed recall (p = .007) scores. On qEEG, the CR Group showed a significant decrease in delta 'slow wave' power (p = .02) and an increase in the frontal distribution of alpha power (p = .04) from T1 to T2.BCS in the CR Group showed immediate and sustained improvements in self-reported cognitive complaints and memory functioning on neurocognitive testing. Results of the qEEG substudy provide some support for neurophysiological changes underlying the Intervention. Copyright © 2015 John Wiley a Sons, Ltd.
-
cognitive rehabilitation Group Intervention for breast cancer survivors results of a randomized clinical trial
Psycho-oncology, 2015Co-Authors: Linda M Ercoli, Laura Petersen, Aimee M Hunter, Steven A Castellon, Lorna Kwan, B A Kahnmills, L M EmbreeAbstract:Author(s): Ercoli, LM; Petersen, L; Hunter, AM; Castellon, SA; Kwan, L; Kahn-Mills, BA; Embree, LM; Cernin, PA; Leuchter, AF; Ganz, PA | Abstract: PurposeWe conducted a randomized clinical trial evaluating the efficacy of a cognitive rehabilitation (CR) Intervention compared with a wait list (WL) control condition on cognitive complaints, neuropsychological and brain functioning in breast cancer survivors (BCS).MethodsThe small Group Intervention of five sessions included psychoeducation and cognitive exercises.EligibilityDisease-free BCS with cognitive complaints, diagnosed with stage I, II or III breast cancer, completed primary treatment 18 months to 5 years earlier. Neurocognitive test data and cognitive complaints on the Patient's Assessment of Own Functioning Inventory (PAOFI) were assessed at baseline (T1), immediately post-Intervention (T2), and 2 months later (T3). A subGroup of participants underwent resting state quantitative electroencephalography (qEEG) at all three assessment time points.ResultsForty-eight participants [mean age (SD) 53.8 (8.2)] completed T1 assessments, and 29 participants had analyzable qEEG data. The CR Group improved significantly over time compared with the WL Group on PAOFI total and memory scores (both p = .01) and on Rey Auditory Verbal Learning Test (RAVLT) total (trials I-V) (p = .02) and RAVLT delayed recall (p = .007) scores. On qEEG, the CR Group showed a significant decrease in delta 'slow wave' power (p = .02) and an increase in the frontal distribution of alpha power (p = .04) from T1 to T2.ConclusionsBCS in the CR Group showed immediate and sustained improvements in self-reported cognitive complaints and memory functioning on neurocognitive testing. Results of the qEEG substudy provide some support for neurophysiological changes underlying the Intervention. Copyright © 2015 John Wiley a Sons, Ltd.
B A Kahnmills - One of the best experts on this subject based on the ideXlab platform.
-
cognitive rehabilitation Group Intervention for breast cancer survivors results of a randomized clinical trial
Psycho-oncology, 2015Co-Authors: Linda M Ercoli, Laura Petersen, Aimee M Hunter, Steven A Castellon, Lorna Kwan, B A Kahnmills, L M EmbreeAbstract:Author(s): Ercoli, LM; Petersen, L; Hunter, AM; Castellon, SA; Kwan, L; Kahn-Mills, BA; Embree, LM; Cernin, PA; Leuchter, AF; Ganz, PA | Abstract: We conducted a randomized clinical trial evaluating the efficacy of a cognitive rehabilitation (CR) Intervention compared with a wait list (WL) control condition on cognitive complaints, neuropsychological and brain functioning in breast cancer survivors (BCS).The small Group Intervention of five sessions included psychoeducation and cognitive exercises.Disease-free BCS with cognitive complaints, diagnosed with stage I, II or III breast cancer, completed primary treatment 18 months to 5 years earlier. Neurocognitive test data and cognitive complaints on the Patient's Assessment of Own Functioning Inventory (PAOFI) were assessed at baseline (T1), immediately post-Intervention (T2), and 2 months later (T3). A subGroup of participants underwent resting state quantitative electroencephalography (qEEG) at all three assessment time points.Forty-eight participants [mean age (SD) 53.8 (8.2)] completed T1 assessments, and 29 participants had analyzable qEEG data. The CR Group improved significantly over time compared with the WL Group on PAOFI total and memory scores (both p = .01) and on Rey Auditory Verbal Learning Test (RAVLT) total (trials I-V) (p = .02) and RAVLT delayed recall (p = .007) scores. On qEEG, the CR Group showed a significant decrease in delta 'slow wave' power (p = .02) and an increase in the frontal distribution of alpha power (p = .04) from T1 to T2.BCS in the CR Group showed immediate and sustained improvements in self-reported cognitive complaints and memory functioning on neurocognitive testing. Results of the qEEG substudy provide some support for neurophysiological changes underlying the Intervention. Copyright © 2015 John Wiley a Sons, Ltd.
-
cognitive rehabilitation Group Intervention for breast cancer survivors results of a randomized clinical trial
Psycho-oncology, 2015Co-Authors: Linda M Ercoli, Laura Petersen, Aimee M Hunter, Steven A Castellon, Lorna Kwan, B A Kahnmills, L M EmbreeAbstract:Author(s): Ercoli, LM; Petersen, L; Hunter, AM; Castellon, SA; Kwan, L; Kahn-Mills, BA; Embree, LM; Cernin, PA; Leuchter, AF; Ganz, PA | Abstract: PurposeWe conducted a randomized clinical trial evaluating the efficacy of a cognitive rehabilitation (CR) Intervention compared with a wait list (WL) control condition on cognitive complaints, neuropsychological and brain functioning in breast cancer survivors (BCS).MethodsThe small Group Intervention of five sessions included psychoeducation and cognitive exercises.EligibilityDisease-free BCS with cognitive complaints, diagnosed with stage I, II or III breast cancer, completed primary treatment 18 months to 5 years earlier. Neurocognitive test data and cognitive complaints on the Patient's Assessment of Own Functioning Inventory (PAOFI) were assessed at baseline (T1), immediately post-Intervention (T2), and 2 months later (T3). A subGroup of participants underwent resting state quantitative electroencephalography (qEEG) at all three assessment time points.ResultsForty-eight participants [mean age (SD) 53.8 (8.2)] completed T1 assessments, and 29 participants had analyzable qEEG data. The CR Group improved significantly over time compared with the WL Group on PAOFI total and memory scores (both p = .01) and on Rey Auditory Verbal Learning Test (RAVLT) total (trials I-V) (p = .02) and RAVLT delayed recall (p = .007) scores. On qEEG, the CR Group showed a significant decrease in delta 'slow wave' power (p = .02) and an increase in the frontal distribution of alpha power (p = .04) from T1 to T2.ConclusionsBCS in the CR Group showed immediate and sustained improvements in self-reported cognitive complaints and memory functioning on neurocognitive testing. Results of the qEEG substudy provide some support for neurophysiological changes underlying the Intervention. Copyright © 2015 John Wiley a Sons, Ltd.
